Register Interest

Science Program

Focus areas for 2017

Focus Areas for 2017 are as follows: 

  • An innovative approach to target identification and/or technology platform in drug discovery for pain.
  • An innovative approach to discovery of novel opioid analgesics without central side effects, such as psychological dependence, sedation and respiratory depression.
  • A unique bioinformatics method to identify novel drug targets, biomarkers and pathogenesis of CNS disorders in emphasis on research to treat impairment of cognitive functions.
  • An approach and/or technology to improve gastrointestinal mucosal permeability of beta-lactam antibiotics.
  • A novel approach to cure (virus eradication) or to functional cure (permanent suppression of viral replication) of human immunodeficiency virus (HIV) infection.
  • A novel approach to cure (virus eradication) or to functional cure (permanent suppression of viral replication) of hepatitis B virus (HBV) infection.
  • A preclinical model of latent HIV infection.
  • A preclinical model of latent HBV infection.
  • A preclinical model of chronic human herpesvirus (HHV) infection.

 (More detailed information is available on http://www.shionogi.co.jp/openinnovation/en/)